Nisa Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Nisa Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,050	Closed	-$41K	–	2413
2020 Q3	$41K	Buy	+13,050	New	+$41.7K	﹤0.01%	1882
2020 Q2	–	Sell	-4,653	Closed	-$13K	–	2156
2020 Q1	$13K	Hold	4,653	–	–	﹤0.01%	1812
2019 Q4	$15K	Sell	4,653 -94,717	-95%	-$275K	﹤0.01%	1752
2019 Q3	$215K	Buy	+99,370	New	+$266K	﹤0.01%	1302
2016 Q3	–	Sell	-2,000	Closed	-$6K	–	1907
2016 Q2	$6K	Hold	2,000	–	–	﹤0.01%	1838
2016 Q1	$7K	Buy	+2,000	New	+$6.24K	﹤0.01%	1829
2015 Q3	–	Sell	-12,000	Closed	-$77K	–	1345
2015 Q2	$77K	Sell	12,000 -5,500	-31%	-$36.8K	﹤0.01%	1285
2015 Q1	$123K	Buy	17,500 +4,500	+35%	+$32.6K	﹤0.01%	1313
2014 Q4	$100K	Hold	13,000	–	–	﹤0.01%	1280
2014 Q3	$97K	Sell	13,000 -10,000	-43%	-$92.8K	﹤0.01%	1295
2014 Q2	$223K	Sell	23,000 -30,000	-57%	-$267K	﹤0.01%	1250
2014 Q1	$440K	Buy	53,000 +40,000	+308%	+$343K	0.01%	1075
2013 Q4	$110K	Buy	13,000 +3,000	+30%	+$25.3K	﹤0.01%	1306
2013 Q3	$80K	Sell	10,000 -10,000	-50%	-$80.4K	﹤0.01%	1301
2013 Q2	$154K	Buy	+20,000	New	+$156K	﹤0.01%	1266

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Nisa Investment Advisors's PDLI Position: Q4 2020 in Review

Nisa Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 13,050 shares — an estimated $41K sold.

Nisa Investment Advisors first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $440K in Q1 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Nisa Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Nisa Investment Advisors sold 13,050 PDL BioPharma, Inc. shares in Q4 2020, an estimated $41K.
Nisa Investment Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
Nisa Investment Advisors's PDL BioPharma, Inc. position peaked at $440K in Q1 2014.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.